Lian-Hua Piao

Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord

The transient receptor potential (TRP) vanilloid type 1 (TRPV1) agonist, capsaicin, enhances glutamatergic spontaneous excitatory synaptic transmission in CNS neurons. Resiniferatoxin (RTX) has a much higher affinity for TRPV1 than capsaicin, but its ability to modulate excitatory transmission is unclear. We examined the effect of RTX on excitatory transmission using the whole-cell patch-clamp technique in substantia gelatinosa (SG) neurons of adult rat spinal cord slices. Bath-applied RTX dose-dependently increased the frequency, but not the amplitude, of spontaneous excitatory postsynaptic current (sEPSC), independent of its application time. In about a half of the neurons tested, this effect was accompanied by an inward current at -70 mV that was sensitive to glutamate-receptor antagonists. Repeated application of RTX did not affect excitatory transmission. RTX was more potent than capsaicin but showed similar efficacy. RTX activity could be blocked by capsazepine or SB-366791, a TRPV1 antagonist, but not tetrodotoxin, a Na(+)-channel blocker, and could be inhibited by pretreatment with capsaicin but not the TRPA1 agonist, allyl isothiocyanate. RTX enhances the spontaneous release of L-glutamate from nerve terminals with similar efficacy as capsaicin and produces a membrane depolarization by activating TRPV1 in the SG, with fast desensitization and slow recovery from desensitization. These results indicate a mechanism by which RTX can modulate excitatory transmission in SG neurons to regulate nociceptive transmission.

TRPA1 activation by lidocaine in nerve terminals results in glutamate release increase

We examined the effects of local anesthetics lidocaine and procaine on glutamatergic spontaneous excitatory transmission in substantia gelatinosa (SG) neurons in adult rat spinal cord slices with whole-cell patch-clamp techniques. Bath-applied lidocaine (1-5 mM) dose-dependently and reversibly increased the frequency but not the amplitude of spontaneous excitatory postsynaptic current (sEPSC) in SG neurons. Lidocaine activity was unaffected by the Na(+)-channel blocker, tetrodotoxin, and the TRPV1 antagonist, capsazepine, but was inhibited by the TRP antagonist, ruthenium red. In the same neuron, the TRPA1 agonist, allyl isothiocyanate, and lidocaine both increased sEPSC frequency. In contrast, procaine did not produce presynaptic enhancement. These results indicate that lidocaine activates TRPA1 in nerve terminals presynaptic to SG neurons to increase the spontaneous release of L-glutamate.

TRPV1 agonist piperine but not olvanil enhances glutamatergic spontaneous excitatory transmission in rat spinal substantia gelatinosa neurons

We examined the effects of TRPV1 agonists olvanil and piperine on glutamatergic spontaneous excitatory transmission in the substantia gelatinosa (SG) neurons of adult rat spinal cord slices with the whole-cell patch-clamp technique. Bath-applied olvanil did not affect the frequency and amplitude of spontaneous excitatory postsynaptic current (sEPSC), and unchanged holding currents at -70 mV. On the other hand, superfusing piperine reversibly and concentration-dependently increased sEPSC frequency (half-maximal effective concentration: 52.3 μM) with a minimal increase in its amplitude. This sEPSC frequency increase was almost repetitive at an interval of more than 20 min. Piperine at a high concentration produced an inward current in some neurons. The facilitatory effect of piperine was blocked by TRPV1 antagonist capsazepine. It is concluded that piperine but not olvanil activates TRPV1 channels in the central terminals of primary-afferent neurons, resulting in an increase in the spontaneous release of l-glutamate onto SG neurons.

Presynaptic facilitation by tetracaine of glutamatergic spontaneous excitatory transmission in the rat spinal substantia gelatinosa – Involvement of TRPA1 channels

The amide-type local anesthetic (LA) lidocaine activates transient receptor potential (TRP) ankyrin-1 (TRPA1) channels to facilitate spontaneous l-glutamate release onto spinal substantia gelatinosa (SG) neurons, which play a crucial role in regulating nociceptive transmission. In contrast, the ester-type LA procaine reduces the spontaneous release of l-glutamate in SG neurons. In order to determine whether TRPA1 activation by LAs is specific to amide-types, we examined the actions of tetracaine, another ester-type LA, and other amide-type LAs on glutamatergic spontaneous excitatory transmission in SG neurons by focusing on TRP activation. Whole-cell patch-clamp recordings were performed on SG neurons of adult rat spinal cord slices at a holding potential of -70mV. Bath-applied tetracaine increased spontaneous excitatory postsynaptic current (sEPSC) frequency in a concentration-dependent manner. Tetracaine activity was resistant to the voltage-gated Na+-channel blocker tetrodotoxin, the TRP vanilloid-1 antagonist capsazepine, and the TRP melastatin-8 antagonist BCTC, but was inhibited by the non-selective TRP antagonist ruthenium red and the TRPA1 antagonist HC-030031. With respect to amide-type LAs, prilocaine had a tendency to increase sEPSC frequency, while ropivacaine and levobupivacaine reduced the frequency. In conclusion, tetracaine facilitated spontaneous l-glutamate release from nerve terminals by activating TRPA1 channels in the SG, resulting in an increase in the excitability of SG neurons. TRPA1 activation was not specific to amide-type or ester-type LAs. The facilitatory action of LAs may be involved in pain occurring after recovery from spinal anesthesia.

Oxytocin produces a membrane depolarization in adult rat spinal substantia gelatinosa neurons

The development of pain after peripheral nerve and tissue injury involves not only neuronal pathways but also glia. However, uncertainty still remains as to the relative contribution of different types of glial cells in the development of the pain-related enhanced response states. We examined the contribution of glial cells to the central sensitization in the rat spinal dorsal horn which is induced in neuropathic pain and inflammatory pain. In rats subjected to neuropathic pain, the immunoreactivity (IR) of microglial marker OX 42 was largely increased. In rats subjected to inflammatory pain, IR of astosytes marker GFAP was slightly increased. The optically-recorded neuronal excitation induced by single-pulse stimulation to the dorsal root was augmented in rats subjected to neuropathic pain and rats subjected to inflammatory pain by comparison to control rats. The bath application of a microglial inhibitor minocycline and a p38 mitogen-activated protein kinase inhibitor SB203580 inhibited the neuronal excitation in rats subjected to neuropathic pain, but not in control and rats subjected to inflammatory pain. PPADS slightly inhibited the neuronal excitation in all group. The additional perfusion of TNP-ATP in PPADS largely inhibited the neuronal excitation in rats subjected to neuropathic pain. In contrast, an astroglial toxin L-alpha-aminoadipate and a gap junction blocker carbenoxolone inhibited the neuronal excitation in rats subjected to inflammatory pain, but not in control and rats subjected to neuropathic pain. The larger number of cells in the spinal cord slice taken from rats subjected to neuropathic pain showed the Ca2+ signal by puff application of ATP to comparison with control and rats subjected to inflammatory pain. The Ca2+ signal was inhibited by minocycline and TNP-ATP. Research fund: KAKENHI22600005.

Opioids reduce the peak amplitude of action potential in adult rat dorsal root ganglion neurons

GABA and glycine are important inhibitory neurotransmitters in the central nervous system and are loaded into synaptic vesicles via the vesicular GABA transporter (VGAT). Due to the evidence linking alterations in GABAergic and/or glycinergic neurotransmission to various pain disorders, we investigated the possible influence of downregulation of VGAT on pain threshold in mice. The phenotypes of heterozygous VGAT knockout (VGAT+/−) mice were compared to wild-type (WT) mice using behavioral and electrophysiological assays. Western blot analysis showed significant reduction of VGAT protein levels in VGAT+/− mice brain (47.8% of WT mice) and spinal cord (61.0% of WT mice). However, HPLC revealed that glutamate, GABA, and glycine contents in the whole brain and spinal cord were no changed in VGAT+/− mice. Although behavioral analysis of VGAT+/− mice showed unchanged motor coordination, anxiety, memory performance and anesthetic sensitivity to propofol and ketamine, thermal nociception and inflammatory pain were enhanced. Patch-clamp recordings revealed that the frequency and amplitude of glycinergic mIPSCs in dorsal horn neurons were reduced in VGAT+/− mice. Genotype differences in glycinergic mIPSCs were more evident during sustained stimulation by high potassium solutions. It seemed that the estimated size of the readily releasable pool (RRP) of glycine-containing vesicles was reduced in VGAT+/− mice. Taken together, our results provide genetic, behavioral and electrophysiological evidence that reduction of VGAT-mediated inhibitory drive in the spinal cord alters very specific forms of pain processing. Research fund: KAKENHI (40447264).